Lipid-based nanocarriers in topical applications for skin infections
- 16 May 2025
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 83, 102541
Abstract
No abstract availableKeywords
Funding Information
- Naresuan University
This publication has 72 references indexed in Scilit:
- Transformative Impact of Nanocarrier‐Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic HorizonsSmall Science, 2024
- Regulatory insights into nanomedicine and gene vaccine innovation: Safety assessment, challenges, and regulatory perspectivesActa Biomaterialia, 2024
- Developing nanosize carrier systems for Amphotericin‐B: A review on the biomedical application of nanoparticles for the treatment of leishmaniasis and fungal infectionsBiotechnology Journal, 2023
- Recent advances in lipid-based long-acting injectable depot formulationsAdvanced Drug Delivery Reviews, 2023
- Exploration of lipidic prodrug‐loaded oil depot system for intramuscular prolonged delivery of entecavirBulletin of the Korean Chemical Society, 2023
- Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physico-chemical critical quality attributesDrug Delivery and Translational Research, 2022
- Bacteria and bacterial derivatives as delivery carriers for immunotherapyAdvanced Drug Delivery Reviews, 2022
- Current hurdles to the translation of nanomedicines from bench to the clinicDrug Delivery and Translational Research, 2021
- Consideration for the scale‐up manufacture of nanotherapeutics—A critical step for technology transferView, 2021
- Lipid Based Nanocarriers: Promising Drug Delivery System for Topical ApplicationEuropean Journal of Lipid Science and Technology, 2021